JUPITER, Fla., Sept. 11, 2019 /PRNewswire/ — Excel Medical, an innovator in modernizing cardiac telemetry and medical device integration (MDI), today announced it entered into a collaboration arrangement with Allina Health, as part of the Lighthouse Program. Excel Medical’s Lighthouse Program creates a unique opportunity for health systems to contribute to the design […]
Financial
iRhythm Technologies Announces Closing of Follow-on Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
SAN FRANCISCO, Sept. 10, 2019 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announced today the closing of its underwritten public offering of 1,575,342 shares of its common stock at a public offering price of $73.00 […]
Milestone Pharmaceuticals Announces Appointment of Amit Hasija as Chief Financial Officer and Executive Vice President of Corporate Development
MONTREAL and CHARLOTTE, N.C., Sept. 10, 2019 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications, today announced the appointment of Amit Hasija as Chief Financial Officer and Executive Vice President of Corporate Development. Mr. Hasija brings to Milestone two decades of […]
InspireMD Provides Business Update
TEL AVIV, Israel, Sept. 09, 2019 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, today provided a business update. Positive CGuard™ EPS Data Presented at the Joint Congress of the World […]
BioSig‘s Subsidiary NeuroClear Technologies, Inc. Raises $3.7 million
Westport, CT, Sept. 05, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that its subsidiary, NeuroClear Technologies, Inc., raised $3.7 million in an initial seed round. […]
Novoheart Holdings Inc. Reports Fourth Quarter and Fiscal 2019 Financial Results
VANCOUVER, British Columbia, Sept. 05, 2019 (GLOBE NEWSWIRE) — Novoheart Holdings Inc. (“Novoheart” or the “Company”) reports financial results for the three and twelve months ended June 30, 2019. Amounts, unless specified otherwise, are expressed in Canadian dollars and are in accordance with International Financial Reporting Standards (IFRS). Ronald Li, […]
iRhythm Technologies Announces Proposed Public Offering of Common Stock
SAN FRANCISCO, Sept. 04, 2019 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announced today that it has commenced an underwritten public offering of $100,000,000 of shares of its common stock. All of the shares in […]
BioTelemetry, Inc. Named to Fortune Magazine’s 100 Fastest-Growing Companies List
MALVERN, Pa., Sept. 03, 2019 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today it has been ranked 31st on Fortune Magazine’s 100 Fastest-Growing Companies list for 2019. The […]
Stereotaxis Announces Uplisting to NYSE American
ST. LOUIS, Sept. 03, 2019 (GLOBE NEWSWIRE) — Stereotaxis (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that its common stock has been approved for listing on the NYSE American. The Company’s common stock will begin trading on the NYSE American exchange under […]
CHF Solutions, Inc. Appoints World-Renowned Heart Failure Cardiologist, Maria Rosa Costanzo, M.D. to Company’s Board of Directors
EDEN PRAIRIE, Minn., Sept. 04, 2019 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (Nasdaq:CHFS) today announced that Maria Rosa Costanzo, M.D. has been appointed to the Company’s Board of Directors. Dr. Costanzo is the medical director, Heart Failure Research, at Advocate Heart Institute, and the medical director for Advanced Heart Failure […]



